Community-acquired, methicillin-resistant Staphylococcus aureus isolated from children with community-onset pneumonia

Wenjing Geng1, Yonghong Yang, Dejing Wu

  • 1Beijing Children's Hospital Affiliated with Capital Medical University, Beijing, China.

Pediatric Pulmonology
|March 17, 2010
PubMed

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pneumonia in Chinese children is primarily linked to the ST59 clone. While many strains were PVL-positive, most did not cause severe necrotic pneumonia.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) causes significant morbidity and mortality globally.
  • Pediatric CA-MRSA pneumonia presents a growing public health concern, particularly in China.

Purpose of the Study:

  • To characterize the molecular and clinical features of pediatric CA-MRSA pneumonia in China.
  • To identify prevalent CA-MRSA strains and associated risk factors in affected children.

Main Methods:

  • Analysis of 55 pediatric CA-MRSA pneumonia strains using multilocus sequence typing (MLST), SCCmec typing, and spa typing.
  • Detection of the Panton-Valentine leukocidin (PVL) gene in isolates.
  • Clinical data collection, including preceding illnesses and disease severity.

Main Results:

  • ST59 was the most prevalent type (40.4%), indicating the spread of the ST59-MRSA-IV clone.
  • New sequence types (ST1409) and spa types (t5348) were identified.
  • 40% of isolates were PVL-positive; however, most PVL-positive strains did not lead to necrotic pneumonia.
  • Preceding influenza or influenza-like illness was reported in 69% of cases.

Conclusions:

  • The ST59-MRSA-IV clone is a major cause of CA-MRSA pneumonia in Chinese children.
  • While PVL is present, it is not solely responsible for severe necrotic pneumonia in this pediatric cohort.
  • Understanding CA-MRSA epidemiology is crucial for effective prevention and treatment strategies in pediatric populations.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...